Brompheniramine
Back to searchMolecule Structure
Scientific Name
Brompheniramine
Description of the Drug
Brompheniramine is a histamine H1 antagonist used to treat coughs, upper respiratory symptoms, and nasal congestion associated with allergies and the common cold.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00835
http://www.drugbank.ca/drugs/DB00835
Brand Name(s)
Not Available
Company Owner(s)
Alkem Laboratories Ltd, Eywa Pharma Inc, Vitarine Pharmaceuticals Inc, Copley Pharmaceutical Inc, Watson Laboratories Inc, Kv Pharmaceutical Co, Newtron Pharmaceuticals Inc, Nexgen Pharma Inc, Rhodes Pharmaceuticals Lp, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4814 | ||
| PharmGKB | PA448675 | ||
| Human Metabolome Database | HMDB0001941 | ||
| DrugBank | DB00835 | ||
| PubChem: Thomson Pharma | 15396259 | ||
| PubChem | 6834 | ||
| LINCS | LSM-1736 | ||
| Nikkaji | J5.569G | J4.936K | J554.571D |
| BindingDB | 50017666 | ||
| EPA CompTox Dashboard | DTXSID5022691 | ||
| DrugCentral | 408 | ||
| Guide to Pharmacology | 7133 | ||
| rxnorm | BROMPHENIRAMINE | BROMPHENIRAMINE MALEATE | |
| KEGG Ligand | C06857 | ||
| ChEBI | 3183 |
